- Home
- STTK vs PXLW Comparison
STTK vs PXLW Comparison
Compare STTK & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- PXLW
- Stock Information
- Founded
- STTK 2016
- PXLW 1997
- Country
- STTK United States
- PXLW United States
- Employees
- STTK N/A
- PXLW N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- STTK Health Care
- PXLW Technology
- Exchange
- STTK Nasdaq
- PXLW Nasdaq
- Market Cap
- STTK 56.8M
- PXLW 49.1M
- IPO Year
- STTK 2020
- PXLW 2000
- Fundamental
- Price
- STTK $1.37
- PXLW $0.81
- Analyst Decision
- STTK Hold
- PXLW Strong Buy
- Analyst Count
- STTK 3
- PXLW 3
- Target Price
- STTK $2.00
- PXLW $2.17
- AVG Volume (30 Days)
- STTK 131.9K
- PXLW 353.1K
- Earning Date
- STTK 03-03-2025
- PXLW 02-12-2025
- Dividend Yield
- STTK N/A
- PXLW N/A
- EPS Growth
- STTK N/A
- PXLW N/A
- EPS
- STTK N/A
- PXLW N/A
- Revenue
- STTK $6,435,000.00
- PXLW $43,206,000.00
- Revenue This Year
- STTK $313.04
- PXLW $10.25
- Revenue Next Year
- STTK N/A
- PXLW $39.19
- P/E Ratio
- STTK N/A
- PXLW N/A
- Revenue Growth
- STTK 382.75
- PXLW N/A
- 52 Week Low
- STTK $0.94
- PXLW $0.61
- 52 Week High
- STTK $11.76
- PXLW $3.08
- Technical
- Relative Strength Index (RSI)
- STTK 60.23
- PXLW 46.76
- Support Level
- STTK $1.21
- PXLW $0.80
- Resistance Level
- STTK $1.36
- PXLW $0.90
- Average True Range (ATR)
- STTK 0.10
- PXLW 0.06
- MACD
- STTK 0.01
- PXLW -0.01
- Stochastic Oscillator
- STTK 90.00
- PXLW 11.96
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.